ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Health Services

Nichii Gakkan Co.

  • 1,741.00 JPY
  • -19.00
  • -1.08%
  • Japan
    Aug 23, 2019
  • Ticker
    TKS(9792)
  • Prev. close
    1,760
  • Market cap (JPY)
    128,512M
  • Market cap (USD)
    1,205.04M
  • Shares
    73.01M

Business Summary

NICHIIGAKKAN CO., LTD. engages in the provision of medical and healthcare services. It operates through the following business segments: Medical, Nursing, Health Care, Education and Other. The Medical segment offers services in medical fee billing, accounting, computer, nursery and medical records management, sterilization, disinfection and sale of medical equipment. The Nursing segment gives home nursing (care plan creation), day care, specific facility (nursing home), dementia cohabitation support (group home), handicapped welfare, visiting nursing and bathing services. It also manages nursery schools and sells and rents out equipment used for welfare. The Health Care segment sells health care products and provides housekeeping, catering, and nursing personnel services. The Education segment gives maternity helper, nursing staff induction and care worker trainings. It also offers medical office courses and English courses. The Other segment involves with data processing; storage and delivery service; publication and sale of books; production and sale of flowers, ornamental plants, seeds and saplings; leasing; personnel service and operation; and management of tourist facilities. The company was founded in December 1968 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2019 JPYUSD
Revenue287,882.95M2,596.00M
Gross Profit53,968.60M486.66M
Operating income10,032.94M90.47M
Income before tax4,180.47M37.69M
Net income6,108.18M55.08M
EBITDA18,291.02M164.94M
Diluted EPS94.750.85
Dividends Per Share350.31
Total Assets193,640.77M1,749.47M
Total liabilities152,562.99M1,378.35M
Total equity40,592.37M366.73M
Operating cash flow13,401.05M120.84M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 271,868.40M 273,583.42M 276,659.88M 283,767.74M 287,882.95M
Gross Profit 50,563.10M 46,216.16M 48,462.75M 50,839.69M 53,968.60M
Operating income 5,173.43M -785.36M 4,206.62M 7,630.16M 10,032.94M
Income before tax 3,025.33M -11,227.67M 1,349.97M 2,845.41M 4,180.47M
Net income 416.03M -15,995.93M 1,403.22M 854.43M 6,108.18M
EBITDA 13,083.36M 7,302.19M 12,246.71M 16,046.69M 18,291.02M
Diluted EPS 6.03 -248.83 21.84 13.27 94.75
Dividends Per Share 20 22 22 22 35
Total Assets 184,554.78M 184,170.13M 191,708.07M 190,239.88M 193,640.77M
Total liabilities 127,869.55M 146,068.25M 153,783.69M 152,583.71M 152,562.99M
Total equity 56,333.22M 37,380.54M 37,124.66M 36,924.35M 40,592.37M
Operating cash flow 10,629.12M 2,546.92M 9,379.04M 15,802.60M 13,401.05M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 2,474.75M 2,278.26M 2,554.86M 2,560.33M 2,596.00M
Gross Profit 460.26M 384.86M 447.53M 458.70M 486.66M
Operating income 47.09M -6.54M 38.84M 68.84M 90.47M
Income before tax 27.53M -93.49M 12.46M 25.67M 37.69M
Net income 3.78M -133.20M 12.95M 7.70M 55.08M
EBITDA 119.09M 60.80M 113.09M 144.78M 164.94M
Diluted EPS 0.05 -2.07 0.20 0.11 0.85
Dividends Per Share 0.18 0.18 0.20 0.19 0.31
Total Assets 1,538.91M 1,638.59M 1,720.43M 1,788.80M 1,749.47M
Total liabilities 1,066.24M 1,299.59M 1,380.09M 1,434.73M 1,378.35M
Total equity 469.73M 332.58M 333.16M 347.19M 366.73M
Operating cash flow 96.75M 21.20M 86.61M 142.58M 120.84M

Valuation Measures

Mar 2019
PER13.71
ROA3.18%
ROE15.75%
Operating margin3.48%
Profit margin2.12%

Key executives

  • Chairman & President: Akihiko Terada
  • Representative Director & Vice President: Daisuke Terada
  • Representative Director & Vice President: Shinsuke Mori
  • Executive Officer & Deputy GM-Accounting: Kazuya Shiitani
  • Director & Senor GM-Corporate Administration: Mitsuo Kaise

Shareholders

  • TERADA AKIHIKO /NICHII GAKKAN/ (37.3%)
  • NICHIIGAKKAN CO., LTD. (11.6%)
  • Effissimo Capital Management Pte Ltd. (11.3%)
  • Mitsubishi UFJ Financial Group, Inc. (2.2%)
  • Nippon Life Insurance Co. (1.6%)
  • The Vanguard Group, Inc. (1.4%)
  • Mizuho Bank Pension Fund (1.3%)
  • Dimensional Fund Advisors LP (1.0%)
  • Norges Bank Investment Management (0.9%)
  • Nomura Asset Management Co., Ltd. (0.8%)

Contact Details

Related Companies

  • Nichiigakkan Restricted Stock Compensation Plan
  • Nichii Shanghai Co. Ltd.
  • SELC Australia Pty Ltd.
  • Meizhou Kejia Dasao Housekeeping Services Co., Ltd.
  • Nichii Hong Kong Ltd.
  • Nichii Gakkan Employee Stock Ownership
  • Nippon Support Service KK
  • Nichii Carenet Co. Ltd.
  • Nihon Credit Lease Corp.
  • Duskin Zero Care Co. Ltd. /Nursing Care Services/
  • Heisei Kaigo KK
  • Nichii Care Palace KK
  • Comsn, Inc. /5 Nursing Care Ops/
  • Comsn Kanto KK
  • Nichii No Kirameki KK
  • Nichii Home KK
  • Nichii No Hohoemi KK
  • NSS Corp.
  • Shiroya Polygon Co. Ltd. /Health Care Ops/
  • Develo Kaigo Center Co. Ltd.
  • Itac Co. Ltd.
  • Keihin Life Service Co. Ltd.
  • GABA Corp.

Competitors

    Last Updated on 23 Aug, 2019

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

    Stay ahead with our exclusives on Asia;
    the most dynamic market in the world.

    Stay ahead with our exclusives on Asia

    Get trusted insights from experts within Asia itself.

    Get trusted insights from experts
    within Asia itself.

    Get Unlimited access

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

    This is your last free article this month

    Stay ahead with our exclusives on Asia; the most
    dynamic market in the world
    .

    Get trusted insights from experts
    within Asia itself.

    Try 3 months for $9

    Offer ends June 30th

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to the Nikkei Asian Review has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media